IHP news 521: Access to medicines

By on May 10, 2019

NBC – Generic HIV prevention drug coming in 2020, Gilead says


Following a campaign by activists, Gilead announced a generic version of Truvada, or PrEP, will be available next September, a year earlier than expected.”

BMJ – Indian campaigners ask government to stop relying on handouts of bedaquiline to ensure supply


Health and patients’ rights groups have asked India’s health ministry to stop depending on donations of bedaquiline from Johnson and Johnson to treat patients with multidrug resistant tuberculosis (MDR-TB) and instead use its own funds to procure the drug. In a letter sent to the health ministry last week, the All India Drug Action Network (AIDAN), a consortium of physicians and health activists, and other groups said dependence on “piecemeal donations” threatened the sustainability and predictability of the government’s plan to treat patients with MDR-TB. They have asked the government to phase out donated bedaquiline and find and treat all patients in India eligible for the bedaquiline based regimen through its domestic budget….”

And a quick link on transparency in the US:

Stat – Drug makers will have to include prices in TV ads as soon as this summer

Leave a reply
Print Friendly, PDF & Email